TrialThe Journal of clinical endocrinology and metabolism2019

Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance.

Martin B Whyte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.